PEG-TNFAlternative Names: PEG-tumour necrosis factor; PEGylated TNF; Pegylated tumour necrosis factor; Polyethylene glycol-bound TNF
Latest Information Update: 04 Apr 2003
At a glance
- Originator National Institute of Bioscience and Human-Technology
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer